Connection

JIANMING XU to Base Sequence

This is a "connection" page, showing publications JIANMING XU has written about Base Sequence.
Connection Strength

0.124
  1. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem. 1995 Mar 17; 270(11):6308-13.
    View in: PubMed
    Score: 0.022
  2. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc Natl Acad Sci U S A. 1994 Aug 16; 91(17):7957-61.
    View in: PubMed
    Score: 0.021
  3. Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. J Biol Chem. 1992 Sep 05; 267(25):17792-803.
    View in: PubMed
    Score: 0.019
  4. Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc Natl Acad Sci U S A. 2006 Nov 07; 103(45):16716-21.
    View in: PubMed
    Score: 0.012
  5. Regulation of insulin secretion and beta-cell mass by activating signal cointegrator 2. Mol Cell Biol. 2006 Jun; 26(12):4553-63.
    View in: PubMed
    Score: 0.012
  6. Dynamic cell type specificity of SRC-1 coactivator in modulating uterine progesterone receptor function in mice. Mol Cell Biol. 2005 Sep; 25(18):8150-65.
    View in: PubMed
    Score: 0.011
  7. Kinase-inactive splice variants of the activin type I receptor. In Vitro Cell Dev Biol Anim. 1996 Mar; 32(3):131-4.
    View in: PubMed
    Score: 0.006
  8. Ligand-specific structural domains in the fibroblast growth factor receptor. J Biol Chem. 1995 Apr 28; 270(17):10222-30.
    View in: PubMed
    Score: 0.006
  9. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. J Biol Chem. 1995 Apr 28; 270(17):10231-5.
    View in: PubMed
    Score: 0.006
  10. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. J Biol Chem. 1993 Jun 15; 268(17):12719-23.
    View in: PubMed
    Score: 0.005
  11. Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors. Loss of binding activity in both two and three loop isoforms. J Biol Chem. 1992 Sep 05; 267(25):17804-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.